Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Prevnar

Known as: Prevenar 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BackgroundSepsis is one of the main reasons for non-elective admission to pediatric intensive care units (PICUs), but little is… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2017
2017
INTRODUCTION BCG vaccination has been associated with beneficial non-specific effects on child health. Some immunological studies… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Background: Pneumococcal conjugate vaccine (PCV) was introduced in the United Kingdom immunization schedule in September 2006… Expand
Is this relevant?
2009
2009
We developed an age-structured, transmission-dynamic, mathematical model to quantify the direct and indirect benefits of infant… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2007
2007
- Despite the availability of antibiotics and the care offered by intensive-care units, invasive pneumococcal disease still… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Aims: Prospective study to evaluate the impact of the 7-valent pneumococcal conjugate vaccine (Prevenar) on the nasopharyngeal… Expand
Is this relevant?
2005
2005
UNLABELLED This study evaluates the safety and immunogenicity of pneumococcal seven-valent conjugate vaccine (Prevenar) in 115… Expand
Is this relevant?
2003
2003
Resume Les affections invasives a pneumocoque representent actuellement une cause majeure de mortalite par maladie infectieuse… Expand
Is this relevant?
2003
2003
UNLABELLED Invasive pneumococcal disease is presently a leading cause of mortality due to bacterial infectious diseases in French… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Heptavalent pneumococcal conjugate vaccine (PCV7) is recommended for universal use in children 23 months and younger, to be given… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?